Literature DB >> 22948788

Future trials of endovascular mechanical recanalisation therapy in acute ischemic stroke patients - a position paper endorsed by ESMINT and ESNR : part II: methodology of future trials.

Jens Fiehler1, Michael Söderman, Francis Turjman, Philip M White, Søren Jacob Bakke, Salvatore Mangiafico, Rüdiger von Kummer, Mario Muto, Christophe Cognard, Jan Gralla.   

Abstract

Based on current data and experience, the joint working group of the European Society of Minimally Invasive Neurological Therapy (ESMINT) and the European Society of Neuroradiology (ESNR) make suggestions on trial design and conduct aimed to investigate therapeutic effects of mechanical thrombectomy (MT). We anticipate that this roadmap will facilitate the setting up and conduct of successful trials in close collaboration with our neighbouring disciplines.

Entities:  

Mesh：

Year:  2012        PMID： 22948788     DOI： 10.1007/s00234-012-1076-y

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  73 in total

1.  Interpretation of operative risks of individual surgeons. European Carotid Surgery Trialists' Collaborative Group.

Authors:  P M Rothwell; C P Warlow
Journal:  Lancet       Date:  1999-04-17       Impact factor: 79.321

2.  Acute stroke: usefulness of early CT findings before thrombolytic therapy.

Authors:  R von Kummer; K L Allen; R Holle; L Bozzao; S Bastianello; C Manelfe; E Bluhmki; P Ringleb; D H Meier; W Hacke
Journal:  Radiology       Date:  1997-11       Impact factor: 11.105

3.  Infarct volume is a pivotal biomarker after intra-arterial stroke therapy.

Authors:  Albert J Yoo; Zeshan A Chaudhry; Raul G Nogueira; Michael H Lev; Pamela W Schaefer; Lee H Schwamm; Joshua A Hirsch; R Gilberto González
Journal:  Stroke       Date:  2012-03-15       Impact factor: 7.914

4.  Assessment of thrombus in acute middle cerebral artery occlusion using thin-slice nonenhanced Computed Tomography reconstructions.

Authors:  Christian H Riedel; Ulf Jensen; Axel Rohr; Marc Tietke; Karsten Alfke; Stephan Ulmer; Olav Jansen
Journal:  Stroke       Date:  2010-07-01       Impact factor: 7.914

5.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

6.  Effect of baseline CT scan appearance and time to recanalization on clinical outcomes in endovascular thrombectomy of acute ischemic strokes.

Authors:  Mayank Goyal; Bijoy K Menon; Shelagh B Coutts; Michael D Hill; Andrew M Demchuk
Journal:  Stroke       Date:  2010-11-18       Impact factor: 7.914

7.  Differences in complication rates among the centres in the SPACE study.

Authors:  Jens Fiehler; Olav Jansen; Jürgen Berger; Hans-Henning Eckstein; Peter A Ringleb; Robert Stingele
Journal:  Neuroradiology       Date:  2008-09-23       Impact factor: 2.804

8.  Predictors of apparent diffusion coefficient normalization in stroke patients.

Authors:  Jens Fiehler; Karina Knudsen; Thomas Kucinski; Chelsea S Kidwell; Jeffry R Alger; Götz Thomalla; Bernd Eckert; Oliver Wittkugel; Cornelius Weiller; Hermann Zeumer; Joachim Röther
Journal:  Stroke       Date:  2004-01-22       Impact factor: 7.914

9.  Should we be performing more randomized controlled trials evaluating surgical operations?

Authors:  M J Solomon; R S McLeod
Journal:  Surgery       Date:  1995-09       Impact factor: 3.982

10.  Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients.

Authors:  Paolo Machi; Vincent Costalat; Kyriakos Lobotesis; Igor Lima Maldonado; Jean Francois Vendrell; Carlos Riquelme; Alain Bonafé
Journal:  J Neurointerv Surg       Date:  2011-04-07       Impact factor: 5.836
View more
  3 in total

1.  Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial.

Authors:  Pooja Khatri; Sharon D Yeatts; Mikael Mazighi; Joseph P Broderick; David S Liebeskind; Andrew M Demchuk; Pierre Amarenco; Janice Carrozzella; Judith Spilker; Lydia D Foster; Mayank Goyal; Michael D Hill; Yuko Y Palesch; Edward C Jauch; E Clarke Haley; Achala Vagal; Thomas A Tomsick
Journal:  Lancet Neurol       Date:  2014-04-27       Impact factor: 44.182

2.  Multivariate dynamic prediction of ischemic infarction and tissue salvage as a function of time and degree of recanalization.

Authors:  André Kemmling; Fabian Flottmann; Nils Daniel Forkert; Jens Minnerup; Walter Heindel; Goetz Thomalla; Bernd Eckert; Michael Knauth; Marios Psychogios; Soenke Langner; Jens Fiehler
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-08       Impact factor: 6.200

3.  Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.

Authors:  Jeffrey L Saver; Mayank Goyal; Alain Bonafe; Hans-Christoph Diener; Elad I Levy; Vitor M Pereira; Gregory W Albers; Christophe Cognard; David J Cohen; Werner Hacke; Olav Jansen; Tudor G Jovin; Heinrich P Mattle; Raul G Nogueira; Adnan H Siddiqui; Dileep R Yavagal; Thomas G Devlin; Demetrius K Lopes; Vivek Reddy; Richard du Mesnil de Rochemont; Reza Jahan
Journal:  Int J Stroke       Date:  2015-04       Impact factor: 5.266
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.